Recombinant Lactobacillus johnsonii UPF0297 protein LJ_0475 (LJ_0475)

Shipped with Ice Packs
In Stock

Description

General Information

Recombinant Lactobacillus johnsonii UPF0297 protein LJ_0475, abbreviated as LJ_0475, is a protein derived from the bacterium Lactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533) . The gene encoding LJ_0475 is part of the UPF0297 family of proteins, with the Uniprot number Q74KV2 .

PropertyValue
Product CodeCSB-YP741550LAW
AbbreviationLJ_0475
Uniprot No.Q74KV2
SourceYeast
Immunogen SpeciesLactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533)
Purity>85% (SDS-PAGE)
Protein LengthFull length protein
Expression Region1-85
Target NamesLJ_0475
Protein NamesRecommended name: UPF0297 protein LJ_0475

Production and Characteristics

LJ_0475 is produced through recombinant technology in yeast cells . The protein has a purity level exceeding 85% as determined by SDS-PAGE . The full-length protein consists of 85 amino acids . The amino acid sequence is: MSSLDKTMHF DFNQNKGKNV YDTLQDVYNA LEEKGYSPIN QIVGYLLSGD PAYIPRHNDA RNLILKHERD EIIEELVKSY LGKNK .

Role of Lactobacillus johnsonii

Lactobacillus johnsonii is a bacterium that plays a key role in maintaining host homeostasis, highlighting its potential as a probiotic . L. johnsonii strains produce hydrogen peroxide, which helps eliminate Salmonella enterica serovar Typhimurium . It also produces lactic acid, which acts with hydrogen peroxide to combat enteric, vaginosis-associated, and uropathogenic pathogens like E. coli, S. typhimurium, and Gardnerella vaginalis . L. johnsonii inhibits the growth of Salmonella enterica serovar Typhimurium SL1344 at a low pH of 4.5, but not at pH 6.5 .

L. johnsonii prevents the adhesion and cell invasion of diarrheagenic bacteria, including enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), Yersinia pseudotuberculosis, and Salmonella typhimurium, to intestinal epithelial cells . The S-layer protein of L. johnsonii F0421 inhibits Shigella sonnei adhesion to HT-29 cells .

L. johnsonii protects against Citrobacter rodentium-induced colitis by modulating innate immune signaling pathways, inflammatory responses, and ER stress . L. johnsonii NJ3 increases the diversity of the intestinal microbiota and improves the diarrhea index, body weight, and liver index in mice infected with enterohemorrhagic E. coli . In vitro studies have shown that L. johnsonii L531 inhibits NLRP3 activity by promoting autophagy, leading to reduced Escherichia coli-induced cell damage . L. johnsonii MT-LB4 has an inhibitory effect on Enterococcus faecalis and planktonic Candida albicans growth in vitro . L. johnsonii produces oleic acid and palmitic acid, which have anti-inflammatory and antifungal properties, during interaction with colonic epithelial cells .

Additional Forms and Modifications

Recombinant Lactobacillus johnsonii UPF0297 protein LJ_0475 is also available with an Avi-tag for biotinylation and can be produced in E. coli, Baculovirus, and Mammalian cells .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
LJ_0475; UPF0297 protein LJ_0475
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-85
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Lactobacillus johnsonii (strain CNCM I-12250 / La1 / NCC 533)
Target Names
LJ_0475
Target Protein Sequence
MSSLDKTMHF DFNQNKGKNV YDTLQDVYNA LEEKGYSPIN QIVGYLLSGD PAYIPRHNDA RNLILKHERD EIIEELVKSY LGKNK
Uniprot No.

Q&A

What are the optimal storage conditions for Recombinant LJ_0475?

The stability of recombinant LJ_0475 is influenced by multiple factors including buffer composition, storage temperature, and handling practices. For optimal preservation:

  • Long-term storage:

    • Liquid form: Store at -20°C/-80°C with shelf life up to 6 months

    • Lyophilized form: Store at -20°C/-80°C with shelf life up to 12 months

  • Working aliquots:

    • Store at 4°C for a maximum of one week

    • Avoid repeated freeze-thaw cycles as these significantly degrade protein integrity

  • Reconstitution protocol:

    • Briefly centrifuge vial before opening

    • Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL

    • Add 5-50% glycerol (with 50% being standard practice) to stabilize the protein for freezing

These conditions optimize protein stability while maintaining structural integrity for experimental applications.

How should researchers prepare LJ_0475 for experimental use?

A methodical approach to preparation enhances experimental reproducibility:

  • Initial handling:

    • Centrifuge the vial before opening to ensure contents reach the bottom

    • Work in sterile conditions to prevent contamination

  • Reconstitution process:

    • Use deionized sterile water to achieve a concentration between 0.1-1.0 mg/mL

    • Add glycerol to a final concentration of 5-50% (typically 50%) to maintain stability during freeze-thaw cycles

  • Aliquoting strategy:

    • Divide the reconstituted protein into single-use aliquots

    • Store primary stock at -80°C

    • Keep working aliquots at 4°C for up to one week

This methodical approach minimizes protein degradation while ensuring consistent experimental inputs across multiple studies.

What methods can be used to achieve high-level expression of LJ_0475 and similar proteins in Lactobacillus species?

Optimizing expression systems for LJ_0475 and related proteins requires strategic selection of both promoters and plasmid backbones. Based on studies with fluorescent protein reporters, several approaches demonstrate enhanced expression:

  • Promoter selection:

    • L-lactate dehydrogenase (ldhL) promoter from Lactobacillus sakei

    • Erythromycin resistance gene promoter (emr)

    • P59 promoter

  • Vector backbone optimization:

    • pLEM415-derived plasmids

    • pUCYIT365N-derived constructs

  • Expression enhancement strategy:

    • Implementation of linking PCR techniques to generate expression constructs

    • Inclusion of FLAG-tag sequences to facilitate detection and purification

The plasmid construction workflow typically involves multiple rounds of PCR to link the promoter region with the protein coding sequence, followed by proper insertion into the selected backbone. This systematic approach has been demonstrated to yield higher expression levels compared to conventional methods for recombinant protein production in Lactobacillus species.

How does LJ_0475 compare to other proteins contained within extracellular vesicles (EVs) of Lactobacillus johnsonii?

Lactobacillus johnsonii produces extracellular vesicles (EVs) containing a diverse protein cargo that includes LJ_0475 among other functional components. Comparative analysis reveals:

This comparison provides context for understanding LJ_0475's potential roles within the broader functional landscape of Lactobacillus johnsonii EVs and their interactions with host cells.

What reconstitution methods are most effective for functional analysis of LJ_0475 in membrane mimetic systems?

As a protein from Lactobacillus johnsonii, LJ_0475 may interact with membrane systems. When studying such interactions, selection of appropriate membrane mimetic systems is crucial:

  • Nanodisc reconstitution approach:

    • Optimal for maintaining native protein conformations

    • Requires careful optimization of protein:phospholipid:MSP ratios

    • Amenable to structural analysis by negative stain electron microscopy (NS-EM) and SEC-MALS

  • DirectMX reconstitution with Saposin lipid nanoparticles (SapNPs):

    • Allows direct membrane extraction without detergent solubilization

    • Preserves protein-lipid interactions critical for maintaining native function

    • Enables downstream characterization by Cryo-EM and surface plasmon resonance (SPR)

  • Peptidisc reconstitution:

    • Versatile approach compatible with proteins of varying sizes and topologies

    • Two effective methods:
      a. "On-beads" reconstitution: Incubation of affinity-bound protein with peptidisc scaffold
      b. Solution reconstitution: Mixing detergent-purified protein with excess peptidisc scaffold followed by SEC separation

    • Supports structure determination by EM and functional analyses including ATPase activity assays and receptor-ligand interaction studies

The selection between these methods should be guided by the specific research objectives, with consideration for the protein's stability, functional requirements, and the analytical techniques planned for subsequent characterization.

What analytical techniques are most suitable for evaluating the structural integrity of reconstituted LJ_0475?

Comprehensive assessment of recombinant LJ_0475 structural integrity requires a multi-technique approach:

  • Biophysical characterization methods:

    • Size-exclusion chromatography (SEC): Evaluates protein homogeneity and oligomeric state

    • SEC-coupled multi-angle light scattering (SEC-MALS): Determines absolute molecular weight and confirms sample monodispersity

    • Negative stain electron microscopy (NS-EM): Provides direct visualization of protein particles and their distribution

  • Advanced structural analysis:

    • Cryo-electron microscopy (Cryo-EM): Enables high-resolution structural determination

    • Native mass spectrometry (nMS): Evaluates protein-lipid or protein-protein interactions under native conditions

  • Functional integrity assessment:

    • Surface plasmon resonance (SPR): Measures binding kinetics with potential interaction partners

    • Biolayer interferometry (BLI): Alternative method for real-time binding analysis

These complementary approaches provide a comprehensive evaluation of LJ_0475's structural and functional properties, particularly important when assessing the impact of different reconstitution methods on protein integrity.

How can researchers optimize experimental designs to study LJ_0475's potential immunomodulatory functions?

Based on studies with Lactobacillus johnsonii extracellular vesicles, which may contain LJ_0475, research into potential immunomodulatory functions should consider:

  • Cellular model selection:

    • Pancreatic β-cell lines (e.g., βlox5) have demonstrated responsiveness to L. johnsonii EVs

    • Consider testing multiple cell types to evaluate tissue-specific responses

  • RNA-mediated immune response assessment:

    • Monitor expression of RNA sensing pathway components:

      • 2'-5'-Oligoadenylate Synthetase (OAS) pathway genes

      • Key markers: OAS, MX, and IFIL genes show maximal transcriptional changes

    • Establish time-course experiments (peak responses observed at approximately 5 hours post-treatment)

  • Endocytosis pathway investigation:

    • Include appropriate controls with endocytosis inhibitors (clathrin/dynamin inhibitors)

    • Track subcellular localization using fluorescently labeled protein and endosomal markers (RAB5, RAB7, LAMP1)

    • Assess endosomal escape using co-localization analysis and calcein assays

  • Systematic data collection:

    • Measure ζ potential of both protein preparations and target cells to predict interaction mechanisms

    • Compare treatments at physiologically relevant (37°C) and inhibitory (4°C) temperatures to distinguish active vs. passive uptake processes

These methodological considerations will enable researchers to systematically investigate LJ_0475's potential immunomodulatory functions while controlling for experimental variables that could influence results interpretation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.